Zymeworks Inc. (NASDAQ: ZYME) presented clinical data for its experimental cancer treatment ZW191 at the European Society for Medical Oncology ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE